相关实验视频
Updated: Jun 16, 2025

11:12
Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation
Published on: July 16, 2014
22.4K
多重系统缩和帕金森病的风险意愿 了解患者的偏好
Alexander Maximilian Bernhardt1,2, Marc Oeller3, Isabel Friedrich4
1Department of Neurology, Ludwig-Maximilians-Universität München, Munich, Germany.
NPJ Parkinson's disease
|August 15, 2024
概括
患者接受治疗风险的意愿在多系统缩 (MSA) 和帕金森氏症中存在显著差异.
科学领域:
- 神经科学是一个神经科学.
- 临床药理学 临床药理学
- 患者报告的结果
背景情况:
- 针对α-synucleinopathies的疾病修饰疗法,如多重系统缩 (MSA) 和帕金森病 (PD),正在开发中.
- 纳入患者偏好,包括风险耐受性,对于治疗开发和监管批准至关重要.
研究的目的:
- 量化和比较患有MSA和PD的患者的治疗相关风险意愿.
- 确定影响这些患者群体风险耐受性的因素.
主要方法:
- 利用标准博场景来评估49名MSA和38名PD患者的风险意愿.
- 分析了对潜在药物或手术副作用的不同严重程度的风险接受.
主要成果:
- 风险愿望在MSA和PD组内和之间显示出显著的差异,具有非高斯分布.
- 对于99%的治愈机会,MSA患者接受了中位数1%的死亡风险;PD患者接受了中位数0.055%的风险.
- 与假设相反,许多MSA患者不愿意接受更高的风险,尽管生活质量受损.
结论:
- 从疾病阶段直接推断到风险意愿是不可行的;对于MSA和PD患者来说,个性化的方法是必不可少的.
- 以患者为中心的风险评估可以帮助监管机构评估安全性,并协助医生进行患者咨询.
- 影响风险耐受性的因素在MSA (生活满意度,情绪/非运动负担) 和PD (年龄,疾病持续时间) 患者之间有所不同.
相关概念视频
Parkinson's Disease: Treatment
240
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
240
Parkinson's Disease: Overview
501
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
501
Neural Regulation
39.2K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.2K

